Comparison

TATA binding protein TBP [1TBP18]

Item no. 20-272-192108
Manufacturer GENWAY
Amount 0.1 mg
Category
Type Antibody
Applications WB, IP
Clone 1TBP18
Specific against other
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias GWB-82A8B8
Similar products 20-272-192108
Available
Genway ID:
GWB-82A8B8
Clone:
1TBP18
Isotype:
IgG1
Immunogen:
Synthetic peptide (Human).
Antigen Species:
HumanEpitope: Within amino acid residues 1-20 of human mouse and rat TBP. The specific epitope for this antibody is accessible when the C-terminal domain of TBP is removed or when TBP is removed or when TBP is complexed with DNA.
Target:
TATA binding protein TBP
Concentration:
Lot specific and is stated on the vial. Storage
Buffer:
PBS with 0. 02% sodium azide
Application Note:
This antibody may be used in Western blot and electrophoretic mobility (gel shift) assays to detect mammalian TBP. It may also be used to immuno-precipitate a truncated TBP molecule containing only the N-terminal domain.
Function:
General transcription factor that functions at the core of the DNA-binding multiprotein factor TFIID. Binding of TFIID to the TATA box is the initial transcriptional step of the pre-initiation complex (PIC) playing a role in the activation of eukaryotic genes transcribed by RNA polymerase II.
Subunit:
Belongs to the TFIID complex together with the TBP-associated factors (TAFs). Component of the transcription factor SL1/TIFIB complex composed of TBP and at least TAF1A TAF1B TAF1C and TAF3. Binds DNA as monomer. Interacts with TAFs TFIIB NCOA6 DRAP1 DR1 and ELF3. Interacts with SPIB SNAPC1 SNAPC2 and SNAPC4. Interacts with HIV-1 Tat. Interacts with UTF1 which acts as a coactivator of ATF2 transcriptional activity. Interacts with GPBP1 (By similarity). Interacts with BRF2.
Subcellular Location:
Nucleus.
Polymorphism:
The poly-Gln region of TBP is highly polymorphic (25 to 42 repeats) in normal individuals and is expanded to about 47-63 repeats in spinocerebellar ataxia 17 (SCA17) patients.
Disease:
Defects in TBP are the cause of spinocerebellar ataxia type 17 (SCA17) [MIM:607136]. Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands speech and eye movements due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA17 is an autosomal dominant cerebellar ataxia (ADCA) characterized by widespread cerebral and cerebellar atrophy dementia and extrapyramidal signs. The molecular defect in SCA17 is the expansion of a CAG repeat in the coding region of TBP. Longer expansions result in earlier onset and more severe clinical manifestations of the disease.
Similarity:
Belongs to the TBP family.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 0.1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close